Browsing Tag
ESMO Congress
2 posts
CytoDyn changed CEOs today. What does Robert Hoffman need to deliver next?
CytoDyn has moved former finance chief Robert Hoffman into the CEO role while Jacob Lalezari returns to scientific work, separating corporate execution from research as leronlimab advances deeper into oncology.
Agenus announces promising trial results for colon cancer treatment at ESMO Congress
Agenus Inc. (Nasdaq: AGEN), a pioneer in the development of immunological agents for cancer treatment, has recently unveiled…